Success Metrics

Active Trials
1(25%)

Phase Distribution

Ph phase_3
1
25%
Ph phase_2
3
75%

Phase Distribution

0

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
3(75.0%)
Phase 3Large-scale testing
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(4)

Detailed Status

Not yet recruiting3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 23 (75.0%)
Phase 31 (25.0%)

Trials by Status

not_yet_recruiting375%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
not_yet_recruitingphase_3

A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment

NCT07601048
not_yet_recruitingphase_2

An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic Cancer

NCT07589569
not_yet_recruitingphase_2

Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

NCT07503639
recruitingphase_2

A Clinical Trial of HRS-7058 Combined Anti-tumor Drugs in Subjects With Solid Tumors

NCT07032077

Clinical Trials (4)

Showing 4 of 4 trials
NCT07601048Phase 3

A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment

Not Yet Recruiting
NCT07589569Phase 2

An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic Cancer

Not Yet Recruiting
NCT07503639Phase 2

Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

Not Yet Recruiting
NCT07032077Phase 2

A Clinical Trial of HRS-7058 Combined Anti-tumor Drugs in Subjects With Solid Tumors

Recruiting

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4